Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone

NCT ID: NCT07082634

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Immediate implant placement in the esthetic zone is an approach that helps preserve soft and hard tissue architecture. However, post extraction bone resorption is still a significant challenge. The socket shield technique (SST) has emerged as a promising way for preserving the buccal plate, potentially improving implant stability and reducing radiographic bone loss. The aim of the present study is to evaluate the clinical and radiographic outcomes of the socket shield technique in the maxillary esthetic zone by assessing implant stability, radiographic bone loss as well as esthetic outcome over a specified follow-up period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Socket Shield Technique Maxillary Esthetic Zone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Socket shield and immediate implant

Group Type EXPERIMENTAL

Socket shield concept and immediate implant placement

Intervention Type PROCEDURE

Tooth Sectioning: The tooth will be sectioned mesiodistally using a fissure bur, preserving the buccal segment.

Palatal fragment extraction: carefully after sectioning the tooth , the palatal fragment is luxated and extracted with the most important factor is taking care of the buccal part not to become loose , the extraction is done using a periotome to be minimally invasive and to preserve the bone from major damage.

Shield Preparation: The buccal fragment is reduced to bone level using a round bur, a beveled edge is created using a diamond football bur, and the shield is thinned to maintain structural integrity.

Implant Site Preparation: Sequential osteotomy performed under copious irrigation, ensuring primary stability.

Implant Placement: A Megagen implant is inserted

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Socket shield concept and immediate implant placement

Tooth Sectioning: The tooth will be sectioned mesiodistally using a fissure bur, preserving the buccal segment.

Palatal fragment extraction: carefully after sectioning the tooth , the palatal fragment is luxated and extracted with the most important factor is taking care of the buccal part not to become loose , the extraction is done using a periotome to be minimally invasive and to preserve the bone from major damage.

Shield Preparation: The buccal fragment is reduced to bone level using a round bur, a beveled edge is created using a diamond football bur, and the shield is thinned to maintain structural integrity.

Implant Site Preparation: Sequential osteotomy performed under copious irrigation, ensuring primary stability.

Implant Placement: A Megagen implant is inserted

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a non-restorable maxillary tooth in the aesthetic zone indicated for extraction and subsequent immediate implant placement.
* Patients with extraction socket Type I.
* A good standard of oral hygiene.

Exclusion Criteria

* Patients with extraction socket Type II or III, with defect in the buccal plate.
* Absence of at least 2 mm bone apical to the extraction socket, necessary to obtain adequate primary stability for the implant assessed by pre-operative radiographic evaluation.
* The presence of any local factor that may interfere with extraction as tooth ankylosis.
* Patients with deciduous teeth.
* Patients with bruxism
* Heavy smokers.
* Systemic conditions that are considered as a contraindication for placement of implant or those that may interfere with wound healing and immunocompromised conditions and uncontrolled autoimmune diseases.
* History of oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months.
* Patients receiving radiotherapy or chemotheraphy.
* Patient with active infection or chronic infection with severe bone loss.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hams Hamed Abdelrahman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hams Hamed Abdelrahman

Lecturer of Dental Public Health and biostatistical consultanat

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beirut Arab University

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohamed M Issa, BDS

Role: CONTACT

+961 76 476 204

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamed M Issa, BDS

Role: primary

+961 76 476 204

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-H-0176-D-M-0796

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.